Sign in
4

Changes in Ownership

Organogenesis Holdings Inc. Filed Acc 0001062993-23-004887

President and CEO acquired 896,414 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Gillheeney Gary S. President and CEO 2023-02-22 Grant or award +896,414 1,774,402 D
Derivatives
Gillheeney Gary S. President and CEO 2023-02-22 Grant or award · Stock Option (Right to Buy) +1,655,381 1,655,381 D
Loading xslF345X03/form4.xml…